Other studies also demonstrate that PKCɛ activity is significantly lower in the AD brain than the control group (Matsushima, Shimohama, Chachin, Taniguchi, & Kimura, 1996; Saitoh et al., 1989). Here, PRRT2 is linked to Alzheimer disease.